113 related articles for article (PubMed ID: 38517223)
1. Performance of Fentanyl Immunoassays in an ED Patient Population.
Mills CM; Dryja PC; Champion-Lyons E; Keppler C; Babic N
J Appl Lab Med; 2024 Mar; ():. PubMed ID: 38517223
[TBL] [Abstract][Full Text] [Related]
2. Detection of 58 fentanyl analogs using ARK fentanyl II and Immunalysis fentanyl immunoassays.
Williams GR; Akala M; Wolf CE
Clin Biochem; 2023 Mar; 113():45-51. PubMed ID: 36610468
[TBL] [Abstract][Full Text] [Related]
3. Performance of Two Fentanyl Immunoassays against a Liquid Chromatography-Tandem Mass Spectrometry Method.
Feng S; Rutledge TJ; Manzoni M; Le T; Gardiner J; Milone M; Shaw L; Wang P
J Anal Toxicol; 2021 Feb; 45(2):117-123. PubMed ID: 32435812
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Two Commercially Available Fentanyl Screening Immunoassays for Clinical Use.
Budelier MM; Franks CE; Logsdon N; Jannetto PJ; Scott MG; Roper SM; Farnsworth CW
J Appl Lab Med; 2020 Nov; 5(6):1277-1286. PubMed ID: 32674121
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a Rapid Drug Test Device for Urine Fentanyl Compared to Mass Spectrometry and 2 Urine Fentanyl Assays.
Laryea ET; Nichols JH
J Appl Lab Med; 2024 Jun; ():. PubMed ID: 38869381
[TBL] [Abstract][Full Text] [Related]
6. A Comparative Analysis of Two Commonly Used FDA-Approved Immunoassays for Fentanyl Detection.
Lam KHB; Menlyadiev M; Buggs V; Parnprome S; Pesce A; Suhandynata RT; Fitzgerald RL; Song L; Metushi IG
J Appl Lab Med; 2024 Jun; ():. PubMed ID: 38831664
[TBL] [Abstract][Full Text] [Related]
7. Performance Evaluation of an Automated Fentanyl Immunoassay.
Tang MS; Lloyd M; Williams M; Farnsworth CW; Budelier MM
J Appl Lab Med; 2021 Sep; 6(5):1192-1201. PubMed ID: 34263303
[TBL] [Abstract][Full Text] [Related]
8. Performance of a Norfentanyl Immunoassay in Specimens with Low Concentrations of Fentanyl and/or Norfentanyl.
Uljon S; Tolan NV; Mahowald GK; Khaliq T; Urwiller ED; Fernandes MD; Basu SS; Kang P; Erickson TB; Hayes BD; Chai PR; Melanson SEF
J Appl Lab Med; 2024 Apr; ():. PubMed ID: 38656327
[TBL] [Abstract][Full Text] [Related]
9. Advances in fentanyl testing.
Uljon S
Adv Clin Chem; 2023; 116():1-30. PubMed ID: 37852717
[TBL] [Abstract][Full Text] [Related]
10. Understand the FDA-cleared fentanyl testing: A clinical evaluation of the SEFRIA fentanyl immunoassay.
Wang D; Sun Q; Schneider R; Cunningham SL
Drug Alcohol Depend; 2024 Jun; 259():111287. PubMed ID: 38640864
[TBL] [Abstract][Full Text] [Related]
11. Polydrug use among patients on methadone medication treatment: Evidence from urine drug testing to inform patient safety.
Saloner B; Whitley P; Dawson E; Passik S; Gordon AJ; Stein BD
Addiction; 2023 Aug; 118(8):1549-1556. PubMed ID: 37158468
[TBL] [Abstract][Full Text] [Related]
12. Comparison of several immunoassays used in drugs of abuse screening: Assessment against gold standard methods and calculation of measurement uncertainty.
Mina A
J Pharmacol Toxicol Methods; 2020; 101():106649. PubMed ID: 31730939
[TBL] [Abstract][Full Text] [Related]
13. URINE TOXICOLOGY PROFILES OF EMERGENCY DEPARTMENT PATIENTS WITH UNTREATED OPIOID USE DISORDER: A MULTI-SITE VIEW.
Cowan E; Perrone J; Dziura J; Edelman EJ; Hawk K; Herring A; McCormack R; Murphy A; Phadke M; Fiellin DA; D'Onofrio G
J Emerg Med; 2023 Oct; 65(4):e357-e365. PubMed ID: 37716904
[TBL] [Abstract][Full Text] [Related]
14. Head to head evaluation of the analytical performance of two commercial methotrexate immunoassays and comparison with liquid chromatography-mass spectrometry and the former fluorescence polarization immunoassay.
Günther V; Mueller D; von Eckardstein A; Saleh L
Clin Chem Lab Med; 2016 May; 54(5):823-31. PubMed ID: 26457783
[TBL] [Abstract][Full Text] [Related]
15. Development and Clinical Validation of a Sensitive Lateral Flow Assay for Rapid Urine Fentanyl Screening in the Emergency Department.
Li Z; Chen H; Feng S; Liu K; Wang P
Clin Chem; 2020 Feb; 66(2):324-332. PubMed ID: 32040576
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the ARK Diagnostics immunoassay for qualitative detection of xylazine in urine.
Patrick BK; Christopher JM; Hua A; Joanne MT; Warren RK; Saldana-Reed A; Douglas FS
J Anal Toxicol; 2024 May; ():. PubMed ID: 38804901
[TBL] [Abstract][Full Text] [Related]
17. A new automated urine fentanyl immunoassay: technical performance and clinical utility for monitoring fentanyl compliance.
Snyder ML; Jarolim P; Melanson SE
Clin Chim Acta; 2011 May; 412(11-12):946-51. PubMed ID: 21281622
[TBL] [Abstract][Full Text] [Related]
18. Cross-reactivity of acetylfentanyl and risperidone with a fentanyl immunoassay.
Wang BT; Colby JM; Wu AH; Lynch KL
J Anal Toxicol; 2014; 38(9):672-5. PubMed ID: 25248490
[TBL] [Abstract][Full Text] [Related]
19. Rate of Fentanyl Positivity Among Urine Drug Test Results Positive for Cocaine or Methamphetamine.
LaRue L; Twillman RK; Dawson E; Whitley P; Frasco MA; Huskey A; Guevara MG
JAMA Netw Open; 2019 Apr; 2(4):e192851. PubMed ID: 31026029
[TBL] [Abstract][Full Text] [Related]
20. Evaluating the performance of the Roche FEN2 fentanyl immunoassay and its clinical implementation: The role of LDT-based mass spectrometry testing.
Menlyadiev M; Suhandynata RT; Lund K; Kelner MJ; Fitzgerald RL
J Mass Spectrom Adv Clin Lab; 2023 Apr; 28():105-113. PubMed ID: 37025609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
